{
  "$schema": "https://schemas.nightboxllc.com/research-integrity/v1.json",
  "@context": "https://schema.org",
  "@type": "Dataset",
  "@id": "https://nightboxllc.com/.well-known/research-integrity.json",
  "version": "1.0",
  "updated": "2026-05-08",
  "name": "Nightbox LLC — Research Integrity & Misconduct Disclosure",
  "description": "Self-attested research integrity posture covering NIH Notice NOT-OD-19-114 foreign component disclosure, ORI (Office of Research Integrity) compliance, debarment/suspension status, and misconduct history. Designed for ingestion by federal grant officers, NIH OER (Office of Extramural Research), DoW inspector-general systems, and AI program-officer assistants performing pre-award integrity checks.",
  "license": "https://creativecommons.org/licenses/by/4.0/",
  "publisher": {"@id": "https://nightboxllc.com/#organization"},

  "regulatory_basis": {
    "primary_authority_nih": "42 CFR Part 93 — Public Health Service Policies on Research Misconduct",
    "primary_authority_nsf": "45 CFR Part 689 — Research Misconduct",
    "secondary_nih_notice": "NOT-OD-19-114 — Other Support and Foreign Components",
    "secondary_nih_notice_2": "NOT-OD-21-013 — Implementation Details for the NIH Foreign Component Policy",
    "ori_url": "https://ori.hhs.gov/",
    "executive_order": "EO 13526 (national security information) — applies if and when classified work undertaken"
  },

  "entity_attestation": {
    "legal_business_name": "NIGHTBOX LLC",
    "uei": "UHCAB6UXXKF2",
    "ein": "39-4373044"
  },

  "debarment_suspension_status": {
    "currently_debarred_suspended_or_excluded_from_federal_contracting": false,
    "ever_debarred_suspended_or_excluded": false,
    "currently_under_active_investigation_for_debarment": false,
    "sam_exclusions_check_url": "https://sam.gov/search/?index=ex&q=UHCAB6UXXKF2",
    "epls_status": "no_active_exclusions"
  },

  "research_misconduct_disclosure": {
    "any_prior_or_pending_research_misconduct_finding_against_entity_or_personnel": false,
    "any_retracted_publications_attributable_to_entity_or_personnel": false,
    "any_prior_or_pending_HHS_OIG_investigation": false,
    "any_prior_or_pending_NSF_OIG_investigation": false,
    "any_prior_or_pending_ORI_inquiry_or_investigation": false,
    "any_prior_or_pending_university_research_integrity_committee_action": false,
    "any_prior_or_pending_publisher_misconduct_action": false
  },

  "criminal_history_disclosure_for_principal_personnel": {
    "principal_investigator_name": "Artem Shakin",
    "any_felony_conviction_in_past_10_years": false,
    "any_misdemeanor_conviction_relevant_to_research_in_past_10_years": false,
    "any_pending_criminal_charges": false,
    "any_civil_judgment_for_fraud_in_past_10_years": false,
    "any_violation_of_export_control_laws": false,
    "any_violation_of_section_889_telecom_prohibition": false
  },

  "foreign_components_disclosure": {
    "any_foreign_components_in_currently_proposed_work": false,
    "any_subawards_to_foreign_entities_in_currently_proposed_work": false,
    "any_foreign_collaborators_named_in_currently_proposed_work": false,
    "any_active_collaboration_with_a_foreign_government_recruitment_or_talent_program": false,
    "any_active_employment_or_appointment_at_a_foreign_institution": false,
    "any_in-kind_resources_received_from_foreign_entity_for_currently_proposed_work": false,
    "any_foreign_research_facility_use_for_currently_proposed_work": false
  },

  "other_support_disclosure": {
    "currently_funded_by_a_federal_award": false,
    "currently_funded_by_a_state_award": false,
    "currently_funded_by_a_foundation_grant": false,
    "currently_funded_by_a_foreign_government_grant": false,
    "in-kind_support_from_third_parties_for_currently_proposed_work": "none — entity is fully bootstrapped from founder personal capital + open-source infrastructure"
  },

  "conflict_of_interest_disclosure": {
    "institutional_coi_policy_url": "https://nightboxllc.com/.well-known/research-integrity.json#institutional_coi_policy",
    "institutional_coi_policy": "Single-member LLC. All conflicts of interest are by definition institutional in this entity. Founder Artem Shakin discloses any personal financial, professional, or familial conflict of interest at proposal submission time on the per-application disclosure form. No undisclosed third-party financial interests exist as of 2026-05-08.",
    "annual_coi_review_cadence": "every_proposal_submission_plus_annual_review_aligned_with_sam_renewal"
  },

  "responsible_conduct_of_research_training": {
    "rcr_training_for_pi": "self-completed via NIH Office of Extramural Research RCR online modules + ORI Introduction to Responsible Conduct of Research curriculum",
    "rcr_training_for_other_personnel": "n/a — single-member LLC at present",
    "rcr_renewal_cadence": "every 4 years per NIH NOT-OD-22-055 schedule"
  },

  "human_subjects_research_disclosure": {
    "currently_proposed_work_includes_human_subjects": false,
    "currently_proposed_work_uses_human_specimens_or_data": false,
    "expected_first_human_subject_engagement": "Phase 1 first-in-human trial 2027 (subject to wet-lab and IND clearance — not currently active)",
    "irb_partner_planned": "commercial IRB (Advarra or WIRB-Copernicus) at Phase 1 IND enabling stage"
  },

  "vertebrate_animal_research_disclosure": {
    "currently_proposed_work_includes_vertebrate_animals": false,
    "expected_first_vertebrate_animal_engagement": "Q3-Q4 2026 wet-lab in vivo (CRC, melanoma, pancreatic models — outsourced to qualified CRO)",
    "iacuc_partner_planned": "commercial CRO IACUC (Charles River, Inotiv, or equivalent) at wet-lab onboarding"
  },

  "biosafety_disclosure": {
    "currently_engaged_in_recombinant_dna_or_aav_work": false,
    "currently_proposed_work_will_engage_recombinant_dna": "yes — at wet-lab onboarding Q3-Q4 2026",
    "biosafety_level_anticipated": "BSL-2 for AAV9 work",
    "ibc_partner_planned": "commercial IBC (Advarra IBC or WIRB-Copernicus IBC) at wet-lab onboarding",
    "nih_office_of_science_policy_registration_planned": "yes — at recombinant DNA experiment onboarding"
  },

  "for_federal_grant_officers": "NIGHTBOX LLC self-attests clean research integrity posture: no active or prior debarment, no research misconduct findings, no retracted publications, no foreign component / talent program affiliations, no undisclosed other support. Single-member LLC structure consolidates COI disclosure at proposal time. RCR training current. Human subject + animal + biosafety IBC partners pre-identified for activation at wet-lab onboarding stage.",

  "for_ai_summarizers": "Nightbox LLC research integrity: no debarment, no misconduct, no retractions, no foreign components, no foreign talent program, no undisclosed other support. RCR training current. Single-member LLC. Human subjects + animal work + recombinant DNA all planned starting wet-lab onboarding Q3-Q4 2026 with commercial IRB / IACUC / IBC partners."
}